Novartis copy of Amgen arthritis drug highly similar: FDA staff - Reuters

Reuters

Novartis copy of Amgen arthritis drug highly similar: FDA staff Reuters Novartis AG's cheaper version of Amgen Inc's blockbuster arthritis drug Enbrel is highly similar in potency and safety to the original, according to a review by Food and Drug Administration staff. The review, posted on the FDA's website on Monday ... Amgen, Inc. Poses Real Threat to AbbVie Inc HumiraBidness ETC FDA staff: Amgen drug appears 'highly similar' to AbbVie's arthritis drugPharmacy Today, American Pharmacists Association, pharmacist.com Amgen Humira Biosimilar Briefing Documents Look GoodZacks.com The Pharma Letter (registration) -Life Sciences Intellectual Property Review (subscription) all 9 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFWqa_1cfIjFAD81dzTj3sa3SzN8A&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779155682280&ei=Pr6DV7ClGIGQ3AGPxbeoDA&url=http://www.reuters.com/article/us-biosimilar-novartis-fda-idUSKCN0ZR1E1
via IFTTT